共同刺激CD28:在癌症免疫治疗中的新见解和应用
Michael T Lotze1,2,3, Scott H Olejniczak4, Dimitris Skokos5
1Department of Surgery, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA, USA. lotzemt@upmc.edu.
Nature reviews. Immunology
|July 25, 2024
概括
最近T细胞信号传递的进步揭示了CD28的存在.
科学领域:
- 免疫学和瘤学
- 分子生物学分子生物学
背景情况:
- 对于癌症免疫疗法来说,T细胞信号传递,特别是共刺激受体CD28非常重要.
- 过去对CD28超激动剂的挑战已经被克服,导致人们对CD28超激动剂重新产生兴趣.
- CD28在T细胞激活中的作用是开发新的癌症治疗方法的关键.
研究的目的:
- 审查最近对CD28分子功能和调节的见解.
- 探索CD28在当前癌症免疫疗法中的核心作用.
- 检查CD28研究如何为未来的瘤治疗策略提供信息.
主要方法:
- 关于CD28.28最近研究的文献综述.
- 分析CD28的分子功能和调节.
- 检查CD28在癌症免疫治疗中的临床应用.
主要成果:
- CD28是现有的癌症免疫疗法的有效性不可或缺的一部分.
- 向的CD28激应是一种有前途的癌症治疗策略.
- 目前对CD28的研究正在提高对其生物作用的理解.
结论:
- CD28的分子功能和调节对于癌症免疫治疗至关重要.
- 对CD28的新见解正在指导下一代瘤治疗药物的开发.
- CD28仍然是推进癌症治疗策略的重要目标.
相关概念视频
Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
T Cell Activation and Clonal Selection
694
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
694


